Drug Eluting Cardiovascular Devices Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

Cardiovascular medical devices such as endovascular grafts, artificial heart valves, coronary stents, and angioplasty balloon catheters save countless lives every year. They can dramatically enhance the quality of life of millions of people. However, the development, design, and manufacturing of advanced implantable cardiovascular devices is a complicated, time-consuming, and investment-intensive process for device manufacturers. A drug-eluting stent (DES) is a peripheral or coronary stent placed into narrowed, infected peripheral or coronary arteries that slowly release a drug to block cell proliferation.

MARKET DYNAMICS

The drug eluting cardiovascular devices market is driving due to the rising demand for minimally invasive cardiovascular procedures, lower post-surgery complications, quicker patient recovery time and shorter hospital stays associated with these procedures. However, lack of awareness regarding drug eluting cardiovascular devices hinders the market's growth. Moreover, growing base of the geriatric population and the rising number of well-trained interventional cardiologists are expected to provide opportunities in the global drug eluting cardiovascular devices market.

MARKET SCOPE

The "Drug Eluting Cardiovascular Devices Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of drug eluting cardiovascular devices market with detailed market segmentation by product and end user. The drug eluting cardiovascular devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in drug eluting cardiovascular devices market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The drug eluting cardiovascular devices market is segmented on the basis of product and end user. Based on product, the market is segmented as drug-eluting stents, bioabsorbable stents, drug-eluting balloons. Based on end user, the market is segmented as hospitals, clinics, others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Drug eluting cardiovascular devices market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The drug eluting cardiovascular devices market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting drug eluting cardiovascular devices market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Drug eluting cardiovascular devices market in these regions.

MARKET PLAYERS

The report covers key developments in the drug eluting cardiovascular devices market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Drug eluting cardiovascular devices market are anticipated to have lucrative growth opportunities in the future with the rising demand for Drug eluting cardiovascular devices in the global market. Below mentioned is the list of few companies engaged in the Drug eluting cardiovascular devices market.

The report also includes the profiles of key players in drug eluting cardiovascular devices market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•   Abbott
  
•   Boston Scientific Corporation
  
•   Cordis Corporation
  
•   B. Braun Melsungen AG
  
•   Medtronic
  
•   Terumo Corporation
  
•   Biotronik
  
•   MicroPort Scientific Corporation
  
•   Sahajanand Medical Technologies
  
•   Cook Medical
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Drug Eluting Cardiovascular Devices Report Scope